Study Assessing Safety and Tolerability of AZD8931 Alone or in Combination With Paclitaxel in Japanese Patients.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms|Metastatic Cancer|Breast Cancer
Interventions: DRUG: AZD8931|DRUG: Paclitaxel
Sponsor: AstraZeneca